Physician profile
Robert G Mutch
NPI 1962434712
$14,957.58
in general payments reported to CMS, 2019-2025
7 companies · $8,817 in 2025
The $8,817 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.56 · 2020: $130 · 2022: $1,500 · 2024: $4,499 · 2025: $8,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $1,108 · Education: $1,000 · Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,600.00 |
| Travel and Lodging | $1,107.95 |
| Education | $1,000.00 |
| Food and Beverage | $608.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $10,600.00 | 2024-2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $3,185.94 | 2020-2025 | |
| Hologic Sales and Service, LLC | $785.21 | 2024-2025 | None, Acessa Provu System |
| Meditrina | $142.98 | 2025 | |
| Acessa Health INC. | $131.26 | 2024 | Acessa Provu System |
| Aspira Women'S Health INC | $100.63 | 2020 | |
| Abbvie INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mutch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.